Bolt Biotherapeutics annual meeting elects three directors, ratifies PwC as auditor

Bolt Biotherapeutics, Inc.

Randall C. Schatzman, Ph.D. elected with 18,339,155 votes for, 49,830 withheld.
Edgar G. Engleman, M.D. elected with 18,300,413 votes for, 88,572 withheld.
James I. Healy, M.D., Ph.D. elected with 14,449,941 votes for, 3,939,044 withheld.
Ratification of PricewaterhouseCoopers LLP as auditor for FY2023: 26,831,426 for, 33,439 against, 15,578 abstain.

item 5.07

Key facts

Extracted from this filing and checked against the source text.

Shareholder Votes SEC 8-K Item 5.07 confidence 0.9

Bolt Biotherapeutics, Inc. shareholders approved Election of Class II directors at the 2023-06-12 meeting.

Proposal: director election
Outcome: passed
Meeting: 2023-06-12

Exact text from the filing

The following director nominees were elected to serve as Class II members of the Company’s board of directors until the Company’s 2026 Annual Meeting of Stockholders, or until their respective successor is duly elected and qualified, or until their respective death, resignation or removal: Nominee Votes For Votes Withheld Broker Non-Votes Randall C. Schatzman, Ph.D. 18,339,155 49,830 8,491,458 Edgar G. Engleman, M.D. 18,300,413 88,572 8,491,458 James I. Healy, M.D., Ph.D. 14,449,941 3,939,044 8,491,458

View on SEC.gov

Shareholder Votes SEC 8-K Item 5.07 confidence 0.9

Bolt Biotherapeutics, Inc. shareholders approved Ratification of PricewaterhouseCoopers LLP as independent registered public accounting firm at the 2023-06-12 meeting.

Proposal: auditor ratification
Outcome: passed
Meeting: 2023-06-12

Exact text from the filing

The selection of PricewaterhouseCoopers LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2023 was ratified. Votes For Votes Against Votes Abstaining 26,831,426 33,439 15,578

View on SEC.gov

352 shareholder votes filed in the last 30 days. Browse all shareholder votes →

Bolt Biotherapeutics, Inc. filing history →

Source: SEC EDGAR

accession 0000950170-23-027743

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.